S&P 500   4,547.87 (-0.06%)
DOW   35,641.65 (+0.60%)
QQQ   390.10 (+0.07%)
AAPL   189.91 (+0.29%)
MSFT   379.07 (+0.06%)
META   333.00 (+0.24%)
GOOGL   135.23 (+0.18%)
AMZN   146.62 (+0.21%)
TSLA   242.34 (-0.74%)
NVDA   480.27 (-0.23%)
NIO   7.23 (+0.70%)
BABA   74.21 (-0.62%)
AMD   123.35 (-0.40%)
T   16.33 (+0.18%)
F   10.54 (-0.47%)
MU   76.64 (-0.07%)
CGC   0.56 (-0.82%)
GE   119.23 (+0.31%)
DIS   93.67 (+1.26%)
AMC   7.02 (-2.09%)
PFE   30.17 (+0.30%)
PYPL   57.70 (-0.47%)
XOM   103.31 (+0.95%)
S&P 500   4,547.87 (-0.06%)
DOW   35,641.65 (+0.60%)
QQQ   390.10 (+0.07%)
AAPL   189.91 (+0.29%)
MSFT   379.07 (+0.06%)
META   333.00 (+0.24%)
GOOGL   135.23 (+0.18%)
AMZN   146.62 (+0.21%)
TSLA   242.34 (-0.74%)
NVDA   480.27 (-0.23%)
NIO   7.23 (+0.70%)
BABA   74.21 (-0.62%)
AMD   123.35 (-0.40%)
T   16.33 (+0.18%)
F   10.54 (-0.47%)
MU   76.64 (-0.07%)
CGC   0.56 (-0.82%)
GE   119.23 (+0.31%)
DIS   93.67 (+1.26%)
AMC   7.02 (-2.09%)
PFE   30.17 (+0.30%)
PYPL   57.70 (-0.47%)
XOM   103.31 (+0.95%)
S&P 500   4,547.87 (-0.06%)
DOW   35,641.65 (+0.60%)
QQQ   390.10 (+0.07%)
AAPL   189.91 (+0.29%)
MSFT   379.07 (+0.06%)
META   333.00 (+0.24%)
GOOGL   135.23 (+0.18%)
AMZN   146.62 (+0.21%)
TSLA   242.34 (-0.74%)
NVDA   480.27 (-0.23%)
NIO   7.23 (+0.70%)
BABA   74.21 (-0.62%)
AMD   123.35 (-0.40%)
T   16.33 (+0.18%)
F   10.54 (-0.47%)
MU   76.64 (-0.07%)
CGC   0.56 (-0.82%)
GE   119.23 (+0.31%)
DIS   93.67 (+1.26%)
AMC   7.02 (-2.09%)
PFE   30.17 (+0.30%)
PYPL   57.70 (-0.47%)
XOM   103.31 (+0.95%)
S&P 500   4,547.87 (-0.06%)
DOW   35,641.65 (+0.60%)
QQQ   390.10 (+0.07%)
AAPL   189.91 (+0.29%)
MSFT   379.07 (+0.06%)
META   333.00 (+0.24%)
GOOGL   135.23 (+0.18%)
AMZN   146.62 (+0.21%)
TSLA   242.34 (-0.74%)
NVDA   480.27 (-0.23%)
NIO   7.23 (+0.70%)
BABA   74.21 (-0.62%)
AMD   123.35 (-0.40%)
T   16.33 (+0.18%)
F   10.54 (-0.47%)
MU   76.64 (-0.07%)
CGC   0.56 (-0.82%)
GE   119.23 (+0.31%)
DIS   93.67 (+1.26%)
AMC   7.02 (-2.09%)
PFE   30.17 (+0.30%)
PYPL   57.70 (-0.47%)
XOM   103.31 (+0.95%)

Virios Therapeutics (VIRI) Insider Trading & Ownership

$0.57
+0.00 (+0.18%)
(As of 09:32 AM ET)
Compare
Today's Range
$0.57
▼
$0.57
50-Day Range
$0.46
▼
$0.96
52-Week Range
$0.22
▼
$2.42
Volume
13,541 shs
Average Volume
1.20 million shs
Market Capitalization
$10.98 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media

Virios Therapeutics (NASDAQ:VIRI) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
10.40%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$51,185.50
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$468.00
Get VIRI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Virios Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

VIRI Insider Buying and Selling by Quarter


Virios Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/21/2023William PridgenDirectorBuy15,335$1.30$19,935.50  
8/17/2023Gregory Scott DuncanCEOBuy25,000$1.25$31,250.00  
12/8/2022Richard James WhitleyDirectorSell1,800$0.26$468.00  
(Data available from 1/1/2013 forward)












VIRI Insider Trading Activity - Frequently Asked Questions

Who is on Virios Therapeutics's Insider Roster?

The list of insiders at Virios Therapeutics includes Angela Walsh, Gregory Scott Duncan, Richard James Whitley, and William Pridgen. Learn more on insiders at VIRI.

What percentage of Virios Therapeutics stock is owned by insiders?

10.40% of Virios Therapeutics stock is owned by insiders. Learn more on VIRI's insider holdings.

Which Virios Therapeutics insiders have been buying company stock?

The following insiders have purchased VIRI shares in the last 24 months: Angela Walsh ($9,160.00), Gregory Scott Duncan ($92,750.00), Richard James Whitley ($11,440.00), and William Pridgen ($168,763.34).

How much insider buying is happening at Virios Therapeutics?

Insiders have purchased a total of 86,089 VIRI shares in the last 24 months for a total of $282,113.34 bought.

Which Virios Therapeutics insiders have been selling company stock?

The following insider sold VIRI shares in the last 24 months: Richard James Whitley ($468.00).

How much insider selling is happening at Virios Therapeutics?

Insiders have sold a total of 1,800 Virios Therapeutics shares in the last 24 months for a total of $468.00 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:VIRI) was last updated on 11/30/2023 by MarketBeat.com Staff

My Account -